These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3029918)
1. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Rakela J; Wiesner RH; Taswell HF; Hermans PE; Smith TF; Perkins JD; Krom RA Transplant Proc; 1987 Feb; 19(1 Pt 3):2399-402. PubMed ID: 3029918 [No Abstract] [Full Text] [Related]
12. [Incidence, therapy and prevention of cytomegalovirus disease after bone marrow transplantation]. Schuler U; Ehninger G Med Klin (Munich); 1992 Oct; 87 Suppl 1():30-8. PubMed ID: 1334220 [No Abstract] [Full Text] [Related]
13. Factors contributing to the risk of cytomegalovirus infection in patients receiving renal transplants. Ho M; Dowling JN; Armstrong JA; Suwansirikul S; Wu B; Youngblood LA; Saslow A Yale J Biol Med; 1976 Mar; 49(1):17-26. PubMed ID: 183377 [No Abstract] [Full Text] [Related]
14. Positive donor cytomegalovirus IgG status as a major risk factor for liver allograft recipient infection. Neumann UP; Knoop M; Langrehr JM; Jonas S; Bechstein WO; Lang M; Neuhaus P Transplant Proc; 1997 Nov; 29(7):2859-60. PubMed ID: 9365592 [No Abstract] [Full Text] [Related]
15. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation. Emery VC; Cope AV; Sabin CA; Burroughs AK; Rolles K; Lazzarotto T; Landini MP; Brojanac S; Wise J; Maine GT J Infect Dis; 2000 Dec; 182(6):1610-5. PubMed ID: 11069231 [TBL] [Abstract][Full Text] [Related]
16. T-helper cell responses in liver transplant recipients: correlation with cytomegalovirus and other major infections. Singh N; Gayowski T; Wagener MM; Zeevi A Transpl Infect Dis; 2004 Jun; 6(2):93-6. PubMed ID: 15522114 [TBL] [Abstract][Full Text] [Related]
17. Some characteristics of the immune response to cytomegalovirus infection. Gönczöl E; Váczi L; Kovács G; Matkó I Acta Microbiol Acad Sci Hung; 1972; 19(2):125-32. PubMed ID: 4362324 [No Abstract] [Full Text] [Related]
18. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718 [TBL] [Abstract][Full Text] [Related]
19. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin. Condie RM; O'Reilly RJ Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370 [No Abstract] [Full Text] [Related]
20. Cytomegalovirus infection and blood transfusion. Beresford CH; Storey G; Faed JM; Milligan LM N Z Med J; 1988 Jan; 101(838):2-4. PubMed ID: 2837706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]